ProShare Advisors
VRDN icon

ProShare Advisors’s Viridian Therapeutics VRDN Stock Holding History

ProShare Advisors’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$199K Sell
14,245
-1,907
-12% -$26.7K ﹤0.01% 1724
2025
Q1 		$218K Sell
16,152
-4,432
-22% -$59.7K ﹤0.01% 1637
2024
Q4 		$395K Buy
20,584
+8,761
+74% +$168K ﹤0.01% 1427
2024
Q3 		$269K Buy
+11,823
New +$269K ﹤0.01% 1535